A Chiral Pool and Cross Metathesis Based Synthesis of Gingerdiols
Compound 12: White solid, m.p. 235–236 °C; ref.[17b] m.p. 227–
1510, 1465, 1417, 1370, 1286, 1268, 1286, 1218, 1199, 1155, 1120,
289.4
[M + Na]+. ESI-HRMS: calcd. for C14H18NaO5 [M + Na]+
229 °C; ref.[17c] m.p. 228–229 °C. 1H NMR (400 MHz, CDCl3): δ = 1033, 967, 905, 865, 823, 754 cm–1. ESI-MS: m/z
=
7.10 (s, 2 H), 7.08 (d, J = 8.0 Hz, 2 H), 7.02 (d, J = 8.0 Hz, 2 H),
7.01 (s, 2 H), 3.89 (s, 6 H), 2.33 (s, 6 H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 169.2, 151.4, 139.6, 136.4, 128.5, 123.1, 119.4, 110.3,
289.1054; found 289.10465.
Cross-Metathesis Reaction Between 10 and Diol 17 To Afford 18:
The same procedure for the CM between 9 and 10 to give 14
(Method A, in CH2Cl2) was employed. Column chromatography
on silica gel (PE/EtOAc, 3:1) afforded 18 (74 mg, 0.19 mmol, 63%
from 17) as a colorless oil. 1H NMR (400 MHz, CDCl3): δ = 6.93–
6.89 (m, 3 H), 6.60 (d, J = 16 Hz, 1 H), 6.18 (dd, J = 5.6, 16 Hz,
1 H), 4.54 (br. q, J = 5.6 Hz, 1 H), 3.95–3.90 (m, 1 H), 3.83 (s, 1
H), 3.88–3.83 (m, 1 H), 3.56 (br. s, 1 H, OH), 2.30 (s, 3 H), 1.89–
1.78 (m, 2 H), 0.92 (s, 9 H), 0.09 (s, 6 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 169.2, 151.2, 139.2, 136.3, 132.6, 129.0,
122.9, 119.2, 110.2, 72.3, 62.2, 55.9, 38.7, 26.0, 20.8, 18.2, –5.4,
56.0, 20.8 ppm. FTIR (film): ν = 1754, 1598, 1514, 1472, 1451,
˜
1422, 1371, 1330, 1301, 1254, 1201, 1168, 1122, 1030, 986, 935,
906, 868, 827 cm–1. ESI-MS: m/z = 357.5 [M + H]+.
Ketone 13: Colorless oil; [α]2D8 = +35.4 (c = 1.12, CHCl3). For the
1
antipode, ref.[18] [α]2D8 = –34.8 (c = 0.34, CHCl3), 93%ee. H NMR
(400 MHz, CDCl3): δ = 4.07–4.00 (m, 1 H), 3.21 (s, 1 H, OH), 2.60
(dd, J = 2.8, 17 Hz, 1 H), 2.51 (dd, J = 9.0, 18 Hz, 1 H), 2.47 (br.
q, J = 7.2 Hz, 1 H), 1.57–1.20 (m, 8 H), 1.06 (t, J = 7.2 Hz, 3 H),
0.89 (t, J = 6.8 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
212.9, 67.7, 48.7, 36.8, 36.5, 31.8, 25.2, 22.6, 14.1, 7.6 ppm. FTIR
(film): ν = 3452, 2956, 2931, 2859, 1709, 1510, 1460, 1408, 1377,
˜
–5.4 ppm. FTIR (film): ν = 3484, 3005, 2953, 2929, 2856, 1766,
˜
1275, 1197, 1211, 1027, 922, 862, 827, 769, 725 cm–1. ESI-MS: m/z
1601, 1509, 1464, 1417, 1369, 1285, 1257, 1198, 1155, 1120, 1095,
=
195.2 [M +
Na]+. ESI-HRMS: calcd. for C10H20NaO2
1034, 1008, 967, 939, 903, 836, 777, 721, 662 cm–1. ESI-MS: m/z =
[M + Na]+ 195.13555; found 195.13565.
403.4 [M
+
Na]+. ESI-HRMS: calcd. for C20H32NaO5Si
[M + Na]+ 403.1911; found 403.1916.
Compound 14: Colorless oil; [α]2D8 = +1.60 (c = 1.31, CHCl3). 1H
NMR (400 MHz, CDCl3): δ = 6.97 (s, 1 H), 6.96 (d, J = 8.3 Hz, 1
H), 6.93 (d, J = 8.3 Hz, 1 H), 6.55 (d, J = 16 Hz, 1 H), 6.16 (dd, J
= 6.4, 16.0 Hz, 1 H), 4.56–4.51 (m, 1 H), 3.96–3.84 (m, 1 H), 3.83
(s, 3 H), 3.25–2.75 (an almost unrecognizable lump, 2 H, OH), 2.31
(s, 3 H), 1.73 (dt, J = 15, 3.3 Hz, 1 H), 1.65 (dd, J = 9.6, 15 Hz, 1
H), 1.56–1.19 (m, 8 H), 0.89 (t, J = 6.8 Hz, 3 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 169.2, 151.2, 139.4, 135.9, 132.5, 129.3,
122.9, 119.3, 110.2, 73.6, 72.7, 55.9, 43.3, 38.3, 31.9, 25.1, 22.7,
Hydrogenation of 14 To Afford 19: A mixture of 14 (82 mg,
0.24 mmol) and 10% Pd-C (8.5 mg) in EtOAc (2.5 mL) was stirred
for 3 h under H2 (1 atm). When TLC indicated that the reaction
had reached completion, the solids were removed by filtration. The
filtrate was concentrated with a rotary evaporator. The residue was
chromatographed on silica gel (PE/EtOAc, 2:1) to furnish 19
(81 mg, 0.24 mmol, 100%) as a colorless oil; [α]2D8 = +11.5 (c =
1.34, CHCl3). 1H NMR (400 MHz, CDCl3): δ = 6.92 (d, J =
7.8 Hz, 1 H), 6.80 (br. s, 1 H), 6.76 (d, J = 8.0 Hz, 1 H), 3.88–3.80
(m, 2 H), 3.80 (s, 3 H), 3.62 (s, 2 H, 2 OH), 2.78–2.71 (m, 1 H),
2.68–2.60 (m, 1 H), 2.29 (s, 3 H), 1.83–1.65 (m, 2 H), 1.60 (br. d,
J = 15 Hz, 1 H), 1.55–1.25 (m, 9 H), 0.89 (t, J = 6.4 Hz, 3 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 169.5, 150.8, 141.2, 137.8, 122.5,
120.5, 112.7, 73.2, 72.2, 55.9, 42.8, 39.7, 38.3, 31.9, 31.6, 25.1, 22.7,
20.8, 14.1 ppm. FTIR (film): ν = 3397, 2931, 2857, 1765, 1600,
˜
1509, 1464, 1416, 1369, 1267, 1197, 1155, 1120, 1033, 967,
903 cm–1. ESI-MS: m/z = 359.4 [M + Na]+. ESI-HRMS: calcd. for
C19H28O5Na [M + Na]+ 359.18290; found 359.1844.
Compound 14Ј: Characterization data were not possible to acquire.
1
The identity was established by comparing the H and 13C NMR
spectroscopic data of (3R,5R)-1 (the antipode of 14Ј) with the extra
20.7, 14.1 ppm. FTIR (film): ν = 3388, 2930, 2857, 1765, 1604,
˜
1
signals in the corresponding H and 13C NMR spectra of the mix-
1510, 1464, 1419, 1369, 1315, 1280, 1217, 1199, 1151, 1122, 1089,
1034, 1010, 936, 901, 846, 827, 726 cm–1. ESI-MS: m/z = 361.4 [M
+ Na]+. ESI-HRMS: calcd. for C19H30NaO5 [M + Na]+ 361.1985;
found 361.1982.
ture of 14 and 14Ј.
Compound 14ЈЈ: Colorless oil; [α]2D9 = +20.4 (c = 0.40, CHCl3). H
1
NMR (400 MHz, CDCl3): δ = 7.53 (d, J = 16 Hz, 1 H), 7.15 (br.
d, J = 8.3 Hz, 1 H), 7.13 (s, 1 H), 7.07 (br. d, J = 8.0 Hz, 1 H),
6.67 (d, J = 16 Hz, 1 H), 4.19–4.09 (m, 1 H), 3.87 (s, 3 H), 3.16
(br. s, 1 H, OH), 2.88 (dd, J = 2.7, 17 Hz, 1 H), 2.76 (dd, J = 9.0,
17 Hz, 1 H), 2.33 (s, 3 H), 1.65–1.52 (m, 2 H), 1.52–1.40 (m, 2
H), 1.40–1.29 (m, 2 H), 0.90 (t, J = 6.3 Hz, 3 H) ppm. 13C NMR
(125 MHz, CDCl3): δ = 200.9, 168.9, 151.7, 142.9, 142.0, 133.3,
126.7, 123.5, 121.8, 111.6, 68.0, 56.1, 47.1, 36.7, 31.9, 25.4, 22.8,
Saponification of 19 To Afford (3R,5S)-1: K2CO3 (15 mg,
0.11 mmol) was added to a solution of 19 (62 mg, 0.18 mmol) in
degassed MeOH (2 mL). The mixture was stirred at ambient tem-
perature for 40 min, which was when TLC indicated that the hy-
drolysis had reached completion. A solution of aqueous HCl (1 n)
was added to acidify the mixture, and the solvent was removed with
a rotary evaporator. The residue was chromatographed on silica gel
(PE/EtOAc, 1:1) to give (3R,5S)-1 (53 mg, 0.18 mmol, 100%) as a
colorless oil. [α]2D8 = +11.8 (c = 1.67, CHCl3); ref.[4] [α]1D4 = +10.4
(c = 1.8, CHCl3); ref.[4] [α]2D5 = +7.5 (c = 1.5, CHCl3); ref.[9a] [α]D
= +11 (c = 1, CHCl3); ref.[2b] [α]2D5 = +8.1 (c = 2, CHCl3). After
exposure to CD3OD, [α]2D7 = +9.3 (c = 0.93, CHCl3). 1H NMR
(400 MHz, CDCl3): δ = 6.82 (d, J = 8.0 Hz, 1 H), 6.70 (br. s, 1 H),
6.68 (d, J = 7.7 Hz, 1 H), 3.90 (a lump, 3 H, OH), 3.85 (s, 3 H),
3.89–3.81 (m, 2 H), 2.69 (ddd, J = 5.7, 9.5, 15 Hz, 1 H), 2.60 (ddd,
J = 7.0, 9.3, 15 Hz, 1 H), 2.62–2.56 (m, 1 H), 1.81–1.62 (m, 2 H),
1.61 (br. d, J = 15 Hz, 1 H), 1.58–1.20 (m, 9 H), 0.88 (t, J = 6.8 Hz,
3 H) ppm. 13C NMR (100 MHz, CDCl3): δ = 146.6, 143.8, 134.0,
121.0, 114.5, 111.2, 73.3, 72.5, 55.9, 42.9, 40.1, 38.3, 31.9, 31.5,
20.8, 14.2 ppm. FTIR (film): ν = 3504, 3009, 2953, 2927, 2855,
˜
1766, 1685, 1650, 1609, 1509, 1466, 1418, 1370, 1297, 1268, 1197,
1159, 1123, 1033, 1011, 980, 903, 822, 724 cm–1. ESI-MS: m/z =
335.3 [M + Na]+. ESI-HRMS: calcd. for C16H26O5Na [M + Na]+
357.16725; found 357.16688.
Cross-Metathesis Reaction Between 10 and Diol 15 To Afford 16:
The same procedure for the CM between 9 and 10 to give 14
(Method A, in CH2Cl2) was employed. Column chromatography
on silica gel (Et2O/CH2Cl2, 4:1) afforded 16 (65 mg, 0.24 mmol,
1
41% from 15) as a colorless oil. H NMR (400 MHz, CDCl3): δ =
6.98–6.92 (m, 3 H), 6.56 (d, J = 16 Hz, 1 H), 6.19 (dd, J = 6.4,
16 Hz, 1 H), 4.53 (br. q, J = 6.0 Hz, 1 H), 3.98–3.76 (m, 2 H), 3.83
(s, 3 H), 2.67 (a lump, 2 H, 2OH), 2.31 (s, 3 H), 1.90–1.80 (m, 2
H) ppm. 13C NMR (100 MHz, CDCl3): δ = 169.3, 151.2, 139.4,
135.9, 132.3, 129.5, 122.9, 119.3, 110.3, 72.4, 61.1, 56.0, 38.6,
1
25.1, 22.7, 14.1 ppm. H NMR (400 MHz, CD3OD): δ = 6.80 (d,
J = 1.2 Hz, 1 H), 6.72 (d, J = 7.9 Hz, 1 H), 6.66 (dd, J = 1.2,
7.8 Hz, 1 H), 3.86 (s, 3 H), 3.82–3.74 (m, 2 H), 2.58 (ddd, J = 5.8,
10, 14 Hz, 1 H), 2.46 (ddd, J = 6.5, 9.6, 14 Hz, 1 H), 1.70–1.55 (m,
20.8 ppm. FTIR (film): ν = 3390, 3006, 2924, 2852, 1763, 1601,
˜
Eur. J. Org. Chem. 2014, 2128–2139
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
2135